Skip to main content
iwCLL 2025 Main banner
Final Program


iwCLL X / Twitter

Poster

1427 - A Prospective Multicenter Study of FCR Alternating with Ibrutinib in Treatment-naive Patients with chronic lymphocytic leukemia (CLL)

    Primary Author / Presenter(s)

  • TW

    Tingyu Wang, MD

    1. State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China； 2. Tianjin Institutes of Health Science，Tianjin 301600, China.
    Tianjin, Tianjin, China (People's Republic)

    • Co-Author(s)

  • Yuting Yan, PhD

    1. State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China； 2. Tianjin Institutes of Health Science，Tianjin 301600, China.
    Tianjin, Tianjin, China (People's Republic)

  • ZL

    Zengjun Li, MD, PhD

    Department of Hematology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences
    Jinan, China (People's Republic)

  • HW

    Hui Wang

    Department of Hematology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117,China
    Jinan, Shandong, China (People's Republic)

  • YS

    Ying Sun

    Department of Hematology, Chifeng Hospital of Inner Mongolia, Chifeng, 024000,China
    Chifeng, Nei Mongol, China (People's Republic)

  • XL

    Xiantao Liu

    Department of Hematology, Chifeng Hospital of Inner Mongolia, Chifeng, 024000,China
    Chifeng, Nei Mongol, China (People's Republic)

  • RL

    Rui Lv

    1. State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China； 2. Tianjin Institutes of Health Science，Tianjin 301600, China.
    Tianjin, China (People's Republic)

  • WX

    Wenjie Xiong, MD

    1. State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China； 2. Tianjin Institutes of Health Science，Tianjin 301600, China.
    Tianjin, China (People's Republic)

  • GA

    Gang An

    State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China, China (People's Republic)

  • WL

    Wei Liu

    1. State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China； 2. Tianjin Institutes of Health Science，Tianjin 301600, China.
    Tianjin, China (People's Republic)

  • YX

    Yan Xu

    1. State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China； 2. Tianjin Institutes of Health Science，Tianjin 301600, China.
    Tianjin, China (People's Republic)

  • SD

    Shuhui Deng

    1. State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China； 2. Tianjin Institutes of Health Science，Tianjin 301600, China.
    Tianjin, Tianjin, China (People's Republic)

  • QW

    Qi Wang

    1. State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China； 2. Tianjin Institutes of Health Science，Tianjin 301600, China.
    Tianjin, China (People's Republic)

  • CD

    Chenxing Du

    1. State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China； 2. Tianjin Institutes of Health Science，Tianjin 301600, China.
    Tianjin, Tianjin, China (People's Republic)

  • DZ

    Dehui Zou

    1. State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China； 2. Tianjin Institutes of Health Science，Tianjin 301600, China., China (People's Republic)

  • YZ

    Yaozhong Zhao

    1. State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China； 2. Tianjin Institutes of Health Science，Tianjin 301600, China.
    Tianjin, Tianjin, China (People's Republic)

  • Lugui Qiu, PhD

    Professor & Director, Department of Lymphoma & Myeloma
    1. State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China； 2. Tianjin Institutes of Health Science，Tianjin 301600, China.
    Tianjin, Tianjin, China (People's Republic)

  • SY

    Shuhua Yi, PhD

    1. State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China； 2. Tianjin Institutes of Health Science，Tianjin 301600, China.
    Tianjin, Tianjin, China (People's Republic)